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MaPatients who are comatose after cardiac arrest continue to be a challenge, with high mortality. Although there is an
American College of Cardiology Foundation/American Heart Association Class I recommendation for performing imme-
diate angiography and percutaneous coronary intervention (when indicated) in patients with ST-segment elevation
myocardial infarction, no guidelines exist for patients without ST-segment elevation. Early introduction of mild thera-
peutic hypothermia is an established treatment goal. However, there are no established guidelines for risk stratiﬁcation of
patients for cardiac catheterization and possible percutaneous coronary intervention, particularly in patients who have
unfavorable clinical features in whom procedures may be futile and affect public reporting of mortality. An algorithm
is presented to improve the risk stratiﬁcation of these severely ill patients with an emphasis on consultation and
evaluation of patients prior to activation of the cardiac catheterization laboratory. (J Am Coll Cardiol 2015;66:62–73)
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survival and neurological outcomes (1,2). The vast
majority of adult cardiac arrests are associated with
obstructive coronary artery disease (3). Emergent cor-
onary revascularization in appropriate patients,
coupled with therapeutic hypothermia (TH) and he-
modynamic support, has continued to improve out-
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AB BR E V I A T I O N S
AND ACRONYM S
ACCF = American College of
Cardiology Foundation
AHA = American Heart
Association
CCL = cardiac catheterization
laboratory
ECG = electrocardiogram
OHCA = out-of-hospital
cardiac arrest
PCI = percutaneous coronary
intervention
ROSC = return of spontaneous
circulation
STE = ST-segment elevation on
electrocardiogram
STEMI = ST-segment elevation
myocardial infarction
TH = therapeutic hypothermia
TTM = targeted temperature
management
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63there are no guidelines for comatose cardiac arrest
patients without ST-segment elevation on electrocar-
diogram (STE).
In patients with OHCA, 64% will be comatose, and
the neurological status on presentation has a dra-
matic effect on subsequent mortality and mortality
(7). Mortality in post-cardiac arrest patients with
STEMI who are awake and undergo successful PCI is
only 5%, but it increases to 50% if patients are
comatose (7).
Although PCI can offer important beneﬁts to
resuscitated patients who remain comatose, current
quality metrics and public reporting programs have
not recognized the expected high mortality rate in
this population and may deincentivize appropriate
care. Whereas door-to-balloon time (D2B) in OHCA
patients is excluded from core measures, hospital and
operator mortality are key performance metrics and
are not excluded. In addition, insurance programs
offer hospitals quality improvement programs with
signiﬁcant ﬁnancial reward if the adjusted mortality
rate after PCI is <1%. Therefore, public reporting
of adverse outcomes in this high-risk population
without adequate risk adjustment, coupled with
ﬁnancial incentives for hospitals with low PCI mor-
tality, has created a signiﬁcant misalignment of goals.
There is concern in the interventional community
that this may lead to risk-averse behavior, resulting in
suboptimal care by not providing early cardiac cath-
eterization to appropriate patients.
RISK STRATIFICATION
Early risk stratiﬁcation of patients with OHCA in the
emergency room and the recommendations for early
angiography vary considerably amongst providers
and institutions. Many regional STEMI systems
include automatic activation of the CCL for all STEMI
and OHCA patients. The role of ﬁrst responders,
emergency room doctors, and noncardiologists fo-
cuses on the process, rather than the appropriateness
of the activation. Although many patients have
improved outcomes with an early invasive approach,
some patient subsets may not derive a beneﬁt and
may experience excess risk.
A strategy to reliably identify patients who beneﬁt
from early angiography and those who beneﬁt from
compassionate supportive care is clearly needed.
An algorithm may assist front line clinicians in iden-
tifying appropriate cardiac arrest patients for emer-
gent cardiac catheterization. Recently, our European
colleagues published a comprehensive review delin-
eating their approach to OHCA patients (8). Although
our approach addresses the care of OHCA patients inthe United States, we hope that continued
universal dialogue and research will accel-
erate improved outcomes in this critically ill
population. We propose an algorithm to best
risk stratify cardiac arrest patients who are
comatose on presentation for emergent CCL
activation for coronary angiography and
possible intervention (Central Illustration).
EXPLANATION OF THE ALGORITHM
The principal purpose of this algorithm is to
provide an easily implementable aid in iden-
tifying appropriate care for all comatose sur-
vivors of cardiac arrest and to identify patients
who are unlikely to receive substantial beneﬁt
from an early invasive approach.
CARDIAC ARREST, RETURN OF SPONTANEOUS
CIRCULATION, AND THE COMATOSE PATIENT.
This algorithm focuses on patients who
have experienced OHCA and have achieved
return of spontaneous circulation (ROSC),
but remain comatose. Although an initial shockable
rhythm, such as ventricular tachycardia (VT) or ven-
tricular ﬁbrillation (VF), improves the likelihood of
ROSC (6,9–11) and of a favorable outcome (12), non-
shockable rhythms may also be caused by coronary
artery occlusion (12).
Successfully resuscitated comatose patients rep-
resent a heterogeneous population with a baseline
survival rate of only 25%. With hypothermia and PCI,
survival improves to 60%, with favorable neurological
outcomes achieved in 86% of survivors (3,4,10,12–15)
(Table 1). However, the presence of certain unfavor-
able features reduces the likelihood of a good
outcome.
TARGETED TEMPERATURE MANAGEMENT WITH MILD
TH AND CORONARY ANGIOGRAPHY POST-CARDIAC
ARREST. Early initiation of targeted temperature
management (TTM) is critical and should neither
delay nor interfere with an early invasive approach.
TTM is the active control of systemic body tempera-
ture to limit tissue injury after ischemia-reperfusion
conditions occurring from cardiac arrest. The use of
mild TH has been demonstrated to improve survival
and neurological outcomes when combined with PCI
in patients with OHCA who remain comatose on
presentation (11,12,16–28). One nonrandomized report
found an associated 20% increase in mortality rate
with every hour of delay in initiating cooling (12).
In 2002, 2 randomized clinical trials found that
lowering body temperature to 32C to 34C for 12 to
24 h in those still comatose after being resuscitated
from VF OHCA improved survival and neurological
CENTRAL ILLUSTRATION Algorithm for Risk Stratiﬁcation of Comatose Cardiac Arrest Patients
ST-segment elevation on the ECG
Out-of-hospital cardiac arrest (OHCA) patients who have achieved return of spontaneous circulation (ROSC), but remain comatose
Within 10 minutes of hospital arrival:
Perform 12-lead electrocardiography (ECG) to identify patients who benefit from emergent angiography
Induce targeted temperature management (TTM) with mild therapeutic hypothermia (TH) to limit tissue injury following cardiac arrest
Patients are less likely to benefit from coronary intervention
Individualized patient care and interventional cardiology 
consultation are strongly recommended
No ST-segment elevation on the ECG
“ACT”
Assess for unfavorable resuscitation features
Consult with interventional cardiology & intensive care services
Transport to cardiac catheterization laboratory (CCL)
(once a decision is made to proceed with coronary angiography)
Patients deemed suitable
Emergency angiography 
Define coronary anatomy
Identify coronary lesion
Percutaneous coronary 
intervention (PCI)
Left ventricular (LV) function 
and hemodynamic assessment   
Provide mechanical LV 
support if needed    
Patients with multiple unfavorable resuscitation features
•  Unwitnessed arrest
•  Initial rhythm: Non-VF
•  No bystander CPR
•   >30 min to ROSC
•  Ongoing CPR
Patients deemed suitable
Early angiography 
Define coronary anatomy
Identify coronary lesion
Percutaneous coronary 
intervention (PCI)
Left ventricular (LV) function 
and hemodynamic assessment   
Provide mechanical LV 
support if needed  
•  pH <7.2
•  Lactate >7
•  Age >85
•  End stage renal disease
• Noncardiac causes (e.g.,traumatic arrest)
Activate ST-segment elevation myocardial infarction (STEMI) team
Consider survival benefit/risk ratio,
 especially if multiple unfavorable resuscitation features are present
Rab, T. et al. J Am Coll Cardiol. 2015; 66(1):62–73.
ACT ¼ assessment, consultation, transport; CCL ¼ cardiac catheterization laboratory; CPR ¼ cardiopulmonary resuscitation; ECG ¼ electrocardiography; LV ¼ left
ventricular; OHCA ¼ out-of-hospital cardiac arrest; PCI ¼ percutaneous coronary intervention; ROSC ¼ return of spontaneous circulation; STEMI ¼ ST-segment elevation
myocardial infarction; TH ¼ therapeutic hypothermia; TTM ¼ targeted temperature management; VF ¼ ventricular ﬁbrillation.
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64function of survivors (16,26). Recently, 2 other ran-
domized clinical trials of TTM in post-resuscitated
patients have found equally impressive survival
rates, whether cooled to 33C versus 36C (24) or
whether initiated in the ﬁeld or after arrival at the
hospital (29). During the decade after the original
reports of TTM efﬁcacy in post-cardiac arrest pa-
tients, clinical cohort studies signaled that the com-
bination of early coronary angiography and TTM
might produce the best outcomes in the resuscitated,
but unconscious, critically ill population. There
are now a total of 28 cohort studies of post-arrest
STEMI patients who were comatose upon hospital
arrival and therefore received TTM and coronary
angiography. A summary of these data shows a
survival to hospital discharge rate of 60%, with
86% of such survivors being neurologically intact
(3,10–12,14,17,22,27,28,30–37) (Table 1).The International Liaison Committee on Resusci-
tation included the following statement in their 2010
International Consensus on Cardiopulmonary Resus-
citation and Emergency Cardiovascular Care Science
with Treatment Recommendations, “Therapeutic
hypothermia is recommended in combination with
primary PCI, and should be started as early as
possible, preferably before initiation of PCI” (38,39),
and the AHA 2010 Guidelines for Cardiopulmonary
Resuscitation and Emergency Cardiovascular Care
states, “angiography and/or PCI need not preclude or
delay other therapeutic strategies including thera-
peutic hypothermia” (39). Within the last few years,
both the European Society of Cardiology 2012 (40)
and the ACCF/AHA 2013 (6) STEMI guidelines
included a Class I recommendation for the use of
TTM for STEMI patients who are resuscitated from
cardiac arrest but remain comatose on arrival at the
TABLE 1 28 Clinical Reports of Combining TTM and Early Coronary Angiography in
Resuscitated, But Comatose Patients With STEMI on the ECG
First Author, Date (Ref. #)
Survivors to DC
(n ¼ 2,687/4,510 [60%])
Good Neuro Among Survivors
(n ¼ 2,090/2,426 [86%])
Hovdenes et al., 2007 (17) 41/50 34/41
Richling et al., 2007 (33) 24/46 22/24
Knafelj et al., 2007 (18) 30/40 22/30
Wolfrum et al., 2008 (22) 12/16 11/12
Peels et al., 2008 (104) 22/44 NA
Schefold et al., 2009 (34) NA 19/31
Reynolds et al., 2009 (14) 52/96 NA
Nielsen et al., 2009 (35) 303/479 278/303
Batista et al., 2010 (27) 8/20 6/8
Dumas et al., 2010 (3) 171/435 160/171
Koeth et al., 2010 (105) 114/143 NA
Stub et al., 2011 (28) 52/81 46/52
Laish-Farkash et al., 2011 (36) 69/110 59/69
Tømte et al., 2011 (37) 140/252 132/140
Radsel et al., 2011 (31) 154/212 128/154
Mooney et al., 2011 (12) 78/140 72/78
Cronier et al., 2011 (11) 60/111 54/60
Gräsner et al., 2011 (90) 143/183 118/143
Bro-Jeppesen et al., 2012 (30) 211/360 207/219
Zanuttini et al., 2012 (10) 29/48 NA
Liu et al., 2012 (106) 36/81 NA
Nanjayya et al., 2012 (59) 18/35 14/18
Strote et al., 2012 (58) 44/61 34/44
Waldo et al., 2013 (107) 57/84 NA
Velders et al., 2013 (32) 187/222 168/183
Callaway et al., 2014 (43) 495/765 413/495
Thomas et al., 2014 (108) 168/348 115/168
Sideris et al., 2014 (88) 97/300 80/97
Values are n/N.
DC ¼ discharge; ECG ¼ electrocardiogram; neuro ¼ neurological function; TTM ¼ targeted temperature
management.
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65hospital (14,37). There are numerous choices for cool-
ing post-arrest patients, including simple ice packs,
intravenous cold saline (1 to 2 l), surface temperature-
regulating devices, intranasal spray devices, and
intravascular catheter-based systems. Although some
are more convenient, none have been shown superior
to the others for patient outcomes (41,42).
The application of TTM, particularly the mainte-
nance of hypothermia, in those undergoing coronary
angiography and PCI, has raised concerns about
possible increased bleeding, particularly from
vascular access sites, and the potential to increase
stent thrombosis. Excess bleeding, seen in earlier
studies of extreme hypothermia (<28C) has not been
seen with the TTM recommended in cardiac arrest
(32C to 36C) (34,43). In the largest report to date,
the Resuscitation Outcomes Consortium reported a
severe bleeding incidence of 2.7% (106 of 3,981)
among all OHCA survivors admitted to the hospital,
with similar rates among those receiving TTM (2.7%;
42 of 1,566), those receiving early coronary angiog-
raphy (3.8%; 29 of 765), and those receiving reperfu-
sion therapy (3.1%; 22 of 705).
There have been 3 reports of increased early stent
thrombosis in patients treated post-arrest with PCI
while simultaneously being cooled (44,45). All were
relatively small series, with a total of 15 of 110 (13.6%)
patients having an acute or subacute stent throm-
bosis. Possible mechanisms include increased platelet
activation, poor absorption of antiplatelet agents,
multiorgan failure with altered metabolism of
antiplatelet/antithrombotic agents, and procoagulant
effects. A fourth report found no increase in stent
thrombosis among the post-cardiac arrest population
receiving both PCI and TTM (2 of 77 ¼ 2.6% vs. 30 of
1,377 ¼ 2.2% in their nonarrested STEMI patients)
(46). The observed increase in stent thrombosis did
not adversely affect long-term outcomes (47,48).
12-LEAD ELECTROCARDIOGRAM. A 12-lead electro-
cardiogram (ECG) should be performed within 10 min
of arrival to identify patients who beneﬁt from
emergent angiography. This should be undertaken
simultaneously with initiation of TH.
STEMI on the ECG. This deﬁnes the Class I recom-
mendation for emergent catheterization laboratory
activation in the ACCF/AHA guidelines (6). There is
substantial evidence demonstrating efﬁcacy of early
angiography and PCI in OHCA patients with STEMI
(3,4,13,14,49–51). Nonetheless, if multiple unfavor-
able resuscitation features are present, the beneﬁt/
futility ratio of proceeding to the catheterization
laboratory should be carefully considered.
No STEMI on the ECG. The presence of an identiﬁ-
able culprit vessel is found in 33% of patients withoutSTEMI. Approximately 70% of these culprit vessels
are occluded (52). Hence, emergent cardiac catheter-
ization to deﬁne a possible ischemic culprit and to
perform revascularization if indicated should be
considered in these patients. There is great clinical
variability in the management of these patients and a
lack of consensus about the best approach to risk
stratiﬁcation and the role of early revascularization
(3,10–12,14,25,28,30,37,43,53–61).
The acronym ACT implies assessment for unfavor-
able resuscitation features, a multidisciplinary team
consultation, including the interventional cardiolo-
gist, and urgent transport to the CCL, once a decision
is made to proceed with coronary angiography.
UNFAVORABLE RESUSCITATION FEATURES. The
presence of unfavorable resuscitation features that
adversely affect the procedural risk/survival beneﬁt
of PCI must be considered prior to reaching a decision
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66to proceed with coronary angiography, especially
when multiple unfavorable features are present.
Patients with unfavorable resuscitation features
are less likely to beneﬁt from coronary intervention.
In these cases, individualized care and interventional
cardiology consultation are strongly recommended.
Multidisciplinary team members should include
physicians from the emergency department, critical
care unit, neurology, cardiology, and interventional
cardiology. All of the following features are relative,
and are not absolute predictors of poor outcomes:
1. Unwitnessed arrest. Extended time without sys-
temic circulation prior to the resuscitation effort
is associated with a decreased ROSC rate (62) and
decreased survival-to-discharge rate (63–66).
When successful ROSC and survival are achieved
after unwitnessed arrest, the rate of favorable
neurological outcome is less than in those with
witnessed arrest (65).
2. Initial rhythm non-VF. Although the presence of
an initial shockable rhythm, such as VT or VF,
improves the likelihood of ROSC (6,9–11) and of a
favorable outcome (12) after PCI to an acute culprit
artery stenosis, severe coronary artery stenosis
may also be present among patients with non-
shockable rhythms (12). Nonshockable rhythms
are associated with worse short- and long-term
outcomes (62–64,67). Patients with an initial
nonshockable rhythm that transforms into a
shockable rhythm fare worse than those present-
ing with an initial shockable rhythm (68).
3. No bystander cardiopulmonary resuscitation.
Recent studies have conﬁrmed that the lack of
bystander cardiopulmonary resuscitation (CPR) is
associated with poor long-term outcomes (62–64).
A recent meta-analysis reported that bystanders
witnessed 53% of cardiac arrests, but only 32% of
cardiac arrests received CPR. Survival was 16.1%
in those who received bystander CPR versus 3.9%
in those who did not (2).
4. Longer than 30 min to ROSC. Early data from in-
hospital cardiac arrest patients found that when
the resuscitation efforts exceeded 30 min, the
survival to discharge wasmarkedly decreased (69).
More recent data from OHCA has demonstrated
similar results (12). Kamatsu et al. (70) found the
mean time to ROSC for those with favorable
(Cerebral Performance Category 1 or 2) neurolog-
ical function post-arrest to be 18 15min compared
with 47  18 min for those with unfavorable
(Cerebral Performance Category 3, 4, or 5) neuro-
logical function (70). Multiple logistic regression
analysis showed a signiﬁcant relationship withthe time interval from receipt of the emergency
call (911) to ROSC. A longer time to ROSC corre-
lated with poor neurological outcome (odds ratio
[OR]: 0.86; 95% conﬁdence interval [CI]: 0.81 to
0.92; p < 0.001) (70).
5. Ongoing CPR. Whereas short CPR duration
(e.g., <16 min) correlates with a favorable prog-
nosis, continuous or ongoing CPR for >30 min,
especially in the presence of unwitnessed arrest,
has been shown to signiﬁcantly reduce the chance
of survival. Additionally, studies have shown that
the duration of CPR is an independent predictor
of poorer functional status after OHCA (71).
6. and 7. Evidence of unresponsive hypoperfusion
and microcirculatory failure (pH and lactate
levels). Cardiac arrest leads to systemic hypo-
perfusion with a low ﬂow state and microcircula-
tory failure resulting in tissue ischemia, anaerobic
metabolism, and the development of lactic
acidosis (72). Normal lactate levels are <1 mmol/l
and correspond to a pH of 7.40. A lactate level of
7 mmol/l corresponds to a pH of 7.2 (72) and sug-
gests a very poor prognosis post-resuscitation.
Lactic acidosis is independently associated with
a 3-fold increase in mortality (72) secondary to
multiorgan failure, including severe anoxic brain
injury with poor neurological outcome (73).
 In the PROCAT (Parisian Region Out of hospital
Cardiac ArresT) study with 435 cardiac arrest
patients, there were 264 nonsurvivors, of whom
112 had a lactate level >7 mmol/l (3,32). In post-
cardiac arrest patients, a pH <7.2 reﬂects severe
acidemia, with increased risk of left ventricular
dysfunction (74,75) and poor neurological re-
covery, whereas those with a pH >7.2 had a
>3-fold chance of neurological recovery (76,77).
 Severe lactic acidosis is present when the lactate
level is >18 mmol/l, corresponding to a pH of 7.0
(72). In the CHEER (Refractory Cardiac Arrest
Treated With Mechanical CPR, Hypothermia,
ECMO and Early Reperfusion) trial, 14 of the 26
enrolled patients with cardiac arrest did not sur-
vive, and their deathswere associatedwith a pHof
6.8 (78).
8. Age >85 years. Although age alone is not an
exclusion criterion, it is a poor prognostic indica-
tor and should be carefully assessed (including
physiological age vs. true age) before an emergent
cardiac catheterization is undertaken. Although
controversial, age needs to be considered, as
studies suggest a worse outcome with advanced
age, particularly in octogenarians (3,11,49,77,79).
Of 179 post-cardiac arrest patients >75 years of age
treated with TH/TTM and PCI, only 33% survived
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67to discharge and only 28% attained good func-
tional recovery (77). In a large registry of patients
>85 years of age, 60% failed to achieve ROSC and
the mortality rate was 90% (80). A recent abstract
from a Danish registry reported a successful
resuscitation rate of only 25% in octogenarians
(mean age 85 years) after cardiac arrest, compared
with 40% among younger patients. Those octoge-
narians who were successfully resuscitated had a
30-day survival of 19% (compared with 45% for
younger patients). However, most who survived in
both groups (75% and 85%, respectively) had good
functional status (81). These studies illustrate the
substantial effect of age on survival, but did not
address the speciﬁc effect of an early invasive
approach. Given the potential challenges of
delineating futility among high-risk patients, we
recommend careful assessment of those >85 years
of age, prior to emergent activation of CCL.
9. End-stage renal disease on hemodialysis.
Compared with the general population, patients
with end-stage renal disease on dialysis are at
increased risk for sudden cardiac arrest. Myocar-
dial ischemia secondary to coronary artery disease
is the primary cause of cardiac arrest. In addition
to the usual triggers of cardiac arrest, hemodial-
ysis patients may have electrolyte derangements
resulting from ﬂuid shifts or changes in pH,
leading to the arrest. Survival rates for dialysis
patients with cardiac arrest are dismal, with <15%
of dialysis patients alive at 1 year (82–84). Of 729
patients who experienced cardiac arrest while in
the hemodialysis unit, 310 (42.5%) were alive at
24 h, with only 80 survivors (11%) at 6 months
(83). There were 110 cardiac arrests at outpatient
dialysis centers in Seattle, Washington, between
1990 and 2004. Only 51 patients (46%) were alive
at 24 h, 26 (24%) survived to hospital discharge,
and only 16 (15%) were alive at 1 year (84). Recent
reviews report mortality in excess of 60% in the
ﬁrst 48 h, with a 1-year mortality of 87% (85–87).
10. Noncardiac causes. Patients with cardiac arrest
due to drugs, drowning, choking, acute stroke,
respiratory failure, terminal cancer, and trauma
are typically not appropriate candidates for emer-
gent cardiac catheterization. Although many of
these patients may have a reasonable prognosis,
it is unlikely to be enhanced by early angiography.
OTHER COMORBIDITIES OR CONTRAINDICATIONS
TO AGGRESSIVE TREATMENT. The effect on post-
arrest outcomes of other comorbidities, such as
advanced dementia, chronic ventilator dependence,
respiratory failure, severe frailty and disability, andother multisystem illnesses are not well characterized
within the published data. However, these conditions
are likely to result in a poor outcome post-
resuscitation and need to be taken into consider-
ation. Moreover, many patients with these conditions
have care plans and do not wish aggressive treatment,
including resuscitation. If it becomes apparent during
the evaluation that a patient did not want to be
resuscitated, an invasive approach should not be
undertaken (77).
IMMEDIATE CORONARY ANGIOGRAPHY IN
PATIENTS WITHOUT STE ON ECG
The majority of patients resuscitated from cardiac
arrest do not have STE on post-arrest ECG
(3,12,30,56,88,89). Although there is strong evidence
to support immediate coronary angiography and PCI
in patients with resuscitated cardiac arrest and
STEMI, data supporting immediate coronary angiog-
raphy in patients without STE is less clear.
Approximately one-fourth of patients without
STE have an acute occlusion (25,31,52,55,58) and
nearly 60% have signiﬁcant obstructive lesions
(3,14,30,31,55,56) (Table 2). Clinical and electrocar-
diographic characteristics are poor predictors of the
presence of an acutely occluded vessel. In 1 report
(53) of 84 patients with cardiac arrest referred for
coronary angiography, the presence of chest pain
preceding the arrest and the presence of STE on ECG
were the only independent predictors of an acute
occlusion (OR: 4.0; 95% CI: 1.3 to 10.1; p ¼ 0.016; and
OR: 4.3; 95% CI: 1.6 to 2.0; p ¼ 0.004, respectively).
However, the positive and negative predictive values
associated with the presence of 1 of these 2 factors
were only 0.63 and 0.74, respectively. If both vari-
ables were present, the positive and negative pre-
dictive values were 0.87 and 0.61, respectively. More
importantly, 11% of patients with an acute coronary
occlusion did not have STE. These data suggest that
coronary angiography remains the “gold standard”
for the identiﬁcation of a culprit artery that may
beneﬁt from early revascularization.
Observational studies have demonstrated that
patients resuscitated from cardiac arrest and re-
ferred for early coronary angiography and/or PCI
have better outcomes, as compared with pa-
tients who are conservatively treated post-arrest
(3,10–12,14,25,28,32,37,43,53–55,58,90) (Table 3). In
all but 1 of these reports, the examined population
included patients with and without STE, which limits
the ability to assess the prognostic effect of early
angiography speciﬁcally in those patients without
STE on ECG. The study by Hollenbeck et al. (25) is the
TABLE 2 Angiographic Findings in Patients With Cardiac Arrest
and No ST-Segment Elevation on ECG
First Author, Year (Ref. #)
Acute
Occlusion
Culprit
Lesion*
Signiﬁcant
CAD†
Merchant et al., 2008 (55) 6/17 (35) — 10/17 (55)
Reynolds et al., 2009 (14) — — 31/54 (57)
Anyfantakis et al., 2009 (56) — — 27/44 (61)
Radsel et al., 2011 (31) 4/54 (7) 13/54 (24) 32/54 (59)
Bro-Jeppesen et al., 2012 (30) — — 43/82 (52)
Dumas et al., 2010 (3) — — 176/301 (58)
Hollenbeck et al., 2014 (25) 44/163 (27) — —
Kern et al., 2015 (52) 23 33 —
Total (%) 23 29 58
Values are n/N (%) or %. *Deﬁned as acute occlusion or irregular plaque
morphology with or without thrombus. †Deﬁned according to the deﬁnition used
in each study.
CAD ¼ coronary artery disease; ECG ¼ electrocardiogram.
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68only report to examine the effect of an early invasive
strategy on neurological outcome and in-hospital
survival in a group of patients resuscitated from car-
diac arrest who did not have STE (25) on ECG. In this
study of 269 comatose patients after cardiac arrest
due to VF or VT, 122 patients (45%) underwent
“early” cardiac catheterization (deﬁned as a proce-
dure performed immediately after hospital admission
or during hypothermia treatment). As compared with
late or no catheterization, early cardiac catheteriza-
tion was associated with a lower adjusted OR for in-
hospital mortality (OR: 0.35; 95% CI: 0.18 to 0.70;
p ¼ 0.003). Furthermore, long-term survival and a
favorable neurological outcome on follow-up were
signiﬁcantly higher in the group of patients referred
for early catheterization (60.0% vs. 40.4%, p ¼ 0.005;
and 60.0% vs. 39.7%, p ¼ 0.004, respectively).
The data summarized in Table 3 support early
coronary angiography in patients after cardiac arrest,
irrespective of the presence or absence of STE.
Although these results imply improved outcomes
among patients referred for cardiac catheterization,
they should be interpreted with caution due to the
observational nature of the studies. Observational
reports are frequently confounded and seldom
adequately control for all factors affecting physicians’
decisions regarding management. Randomized con-
trolled trials of early coronary angiography versus
no or late coronary angiography in patients without
STE after cardiac arrest are needed. Until then, we
recommend proceeding with coronary angiography in
appropriate patients. The principal goal of angiog-
raphy is to deﬁne the coronary anatomy and identify
culprit lesions that require urgent PCI. Coronary
anomalies would also be noted. If angiography is
considered, it should be done early after hospitalpresentation. In the study by Hollenbeck et al. (25),
early angiography was deﬁned as a procedure within
the ﬁrst 24 h. We favor a quicker time to angiography,
ideally as soon as possible after the initial triage and
assessment for unfavorable features (as outlined in
our algorithm), with an emphasis on emergent
consultation by a multidisciplinary team. Patients
unlikely to beneﬁt from coronary angiography and
possible PCI should be identiﬁed early and should not
proceed to the catheterization laboratory. In patients
referred for angiography, the decision to proceed
with PCI should be on the basis of the angiographic
ﬁndings, coupled with the hemodynamic and elec-
trical status of the patient.
THE CHALLENGES OF PUBLIC REPORTING
Although several states have been publicly reporting
PCI outcomes for years, the passage of the Patient
Protection and Affordable Care Act in 2010 increased
the focus on public reporting and quality improve-
ment. The National Quality Forum recently endorsed
risk-adjusted total in-hospital PCI mortality and
30-day all-cause risk-standardized PCI mortality
with STEMI and/or cardiogenic shock for public
reporting (91).
Although paved with noble intentions, public
reporting of mortality can have unintended conse-
quences, possibly promoting risk-averse behaviors
that negatively affect the patients who potentially
have themost to gain from the procedure (92). Patients
with OHCA and ROSC have an approximately 10-fold
higher mortality rate than non–cardiac arrest patients
with STEMI (5). Furthermore, most of the mortality in
this population is due to neurological complications
or multiorgan failure, despite receiving appropriate
care. Moreover, current risk modeling does not
adequately adjust for these extremes of risk, and high
volumes of cardiac arrest patients can adversely affect
individual and institutional outcomes. This is partic-
ularly important in the context of lower-volume cen-
ters, where patients who are appropriately treated
for OHCA can have an outsized effect on mortality
rates. Public reporting inadvertently places clinicians
in the difﬁcult situation of having to choose between
what may be in their patient’s interest and what may
be best for their own quality metrics or for their hos-
pital’s reported outcomes.
Importantly, there is little evidence that public
reporting of mortality improves outcomes in PCI,
especially for patients with OHCA. In fact, several
studies evaluating the effect of public reporting on
PCI mortality in New York, Massachusetts, and
Pennsylvania suggest that risk-averse behaviors
TABLE 3 Outcomes of Patients With Cardiac Arrest Referred for Coronary Angiography
First Author, Year (Ref. #) No STE
Early CAG Group
(Includes Patients With and Without
STE, Unless Otherwise Indicated) No/Late CAG Group
CommentsEarly CAG
PCI
(% of CAG)
Survival/Good
Outcome
(% of CAG)
No/Late
CAG PCI
Survival/Good
Outcome
Spaulding et al., 1997 (53) 49 (58) 84 (99) 37 (44) 32 (38) 1 (1) — 0 (0) All patients were intended to receive CAG;
adjusted odds for survival with successful
PCI: 5.2; 95% CI: 1.1–24.5; p ¼ 0.04.
Werling et al., 2006 (54) NA 24 (28) 13 (54) 16 (67) 61 (72) — 11 (18) The majority of CAG patients had STEMI;
adjusted analysis not performed; unadjusted
OR for survival with CAG: 9.1; 95% CI:
3.6–21.5; p < 0.0001.
Merchant et al., 2008 (55) 17 (57)* 30 (27) 18 (60) 24 (80) 80 (73) — 43 (54) Adjusted odds for survival overall with CAG:
3.8; 95% CI: 1.35–10.90; p < 0.05; in patients
without STE OR: 3.01; 95% CI: 0.84–10.8;
p ¼ 0.091.
Reynolds et al., 2009 (14) 189 (78) 96 (40) 48 (50) 52 (54) 145 (60) — 36 (25) Propensity-adjusted logistic regression OR for
good neurological outcome with CAG: 2.16;
95% CI: 1.12–4.19; p < 0.02.
Anyfantakis et al., 2009 (56) 49 (68) 72 (100) 25 (35) 35 (49) — — — All patients studied got CAG; by multivariate
analysis, attempted PCI was not an independent
predictor of improved survival.
Dumas et al., 2010 (3) 301 (69) 435 (100) 202 (46) 171 (39) — — — All patients studied got CAG; successful PCI was
an independent predictor of survival, adjusted
OR: 2.06; 95% CI: 1.16–3.66; p ¼ 0.013.
Nanjayya et al., 2011 (59) NA 35 (50) 21 (60) 18 (51) 35 (50) 1 (2) 12 (34) Adjusted odds for survival with good neurological
outcome with CAG: 1.32; 95% CI: 0.26–7.37;
p ¼ 0.78.
Mooney et al., 2011 (12) 72 (51) 101 (72) 56 (55) 63 (62) 39 (29) — 15 (38) It is not indicated whether the use of CAG was
included in the multivariate analysis of factors
related to survival.
Aurore et al., 2011 (61) 367 (82) 133 (30) 71 (53) 30 (23) 312 (70) — 30 (9.6) p values for comparisons not provided.
Tømte et al., 2011 (37) NA 145 (83) 80 (55) 76 (52) 29 (17) — 9 (31) Adjusted odds for good outcome with emergency
CAG: 11.21; 95% CI: 2.96–42.49; p < 0.001.
Stub et al., 2011 (28) 46 (37) 82 (66) 41 (50) — 43 (34) — — Also included conscious patients; unadjusted OR
for survival with CAG: 7.6; 95% CI: 3.2–17.5;
p ¼ 0.01. Adjusted analysis not performed.
Strote et al., 2012 (58) 158 (66) 61 (25) 38 (62) 44 (72) 179 (75) 13 (30)† 87 (49) Assessed survival by terciles of likelihood of
getting CAG. In highest tercile group, survival
was higher with early CAG (73% vs. 33%;
p ¼ 0.001).
Zanuttini et al., 2012 (10) 61 (66) 48 (52) 25 (52) 29 (60) 45 (48) 6 (33)† 21 (47) Adjusted odds for survival overall with successful
PCI: 2.32; 95% CI: 1.23–4.38; p ¼ 0.009.
Cronier et al., 2011 (11) 61 (55) 91 (82) 46 (51) NA — — — Only patients without hemodynamic instability got
CAG; adjusted OR for death with PCI: 0.30;
95% CI: 0.11–0.79; p ¼ 0.01.
Bro-Jeppesen et al., 2012 (30) 244 (68) 82 (34)* 24 (29)* 54 (66)* 162 (66)* — 83 (53)* Adjusted HR for mortality in with emergency
CAG in group without STE: 0.69; 95% CI:
0.4–1.2; p ¼ 0.18.
Søholm et al., 2013 (60) 1,020 (84) 128 (13)* NA NA 892 (87)* NA NA Univariate OR for 30-day mortality with early
CAG: 0.35; 95% CI: 0.18–0.70; p ¼ 0.003;
early CAG was not an independent predictor
of mortality.
Hollenbeck et al., 2014 (25) 269 (100) 122 (45) 40 (33) 80 (66) 147 (55) 16 (11)† 71 (49) Adjusted OR for mortality with CAG: 0.35;
95% CI: 0.18–0.70; p ¼ 0.003.
Callaway et al., 2014 (43) 3,408 (86) 765 (19) 705 (92) 495 (65) 3,216 (81) — 871 (27) Adjusted OR for survival with early CAG:
1.69; 95% CI: 1.06–2.70
Values are n (%). *Among those without STE. †Among those getting CAG.
CAG ¼ coronary angiography; CI ¼ conﬁdence interval; HR ¼ hazard ratio; NA ¼ not available; OR ¼ odds ratio; PCI ¼ percutaneous coronary intervention; STE ¼ ST-segment elevation;
STEMI ¼ ST-segment elevation myocardial infarction.
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69related to public reporting may actually negatively
affect patient outcomes. The 3 public reporting states
rank 42nd, 48th, and 50th for utilization of PCI for
acute myocardial infarction, a guideline-supportedindication (93). Furthermore, the adjusted mortality
for patients presenting with STEMI is 35% higher in
states with public reporting compared with those
without public reporting. This is, in part, related to
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70lower utilization of angiography and PCI in patients
with STEMI (61.8% vs. 68%; OR: 0.73; 95% CI: 0.59 to
0.89; p ¼ 0.002), including patients with either
cardiogenic shock or cardiac arrest (41.5% vs. 46.7%;
OR: 0.79; 95% CI: 0.64 to 0.98; p ¼ 0.03) compared
with states that do not publicly report mortality out-
comes. This lower utilization of revascularization and
higher mortality for cardiac arrest patients in states
with public reporting was echoed in an analysis of
84,121 patients from the National Inpatient Sample
database (94). Interestingly, in Massachusetts, the
rates of PCI were similar to those in other non-
reporting states prior to public reporting, but began to
diverge after public reporting was implemented,
strongly implicating public reporting in the decline in
optimal care. Finally, being identiﬁed as a “negative
outlier” in risk-adjusted mortality in Massachusetts
has been associated with a signiﬁcant decline in
predicted mortality in subsequent years, suggesting
that risk-averse behaviors led to the exclusion of
critically ill patients (95).
Given these limitations in public reporting of PCI
mortality, especially in patients at extreme risk, such
as OHCA patients, we endorse the recommendations
set forth in the scientiﬁc statement from the AHA:
“OHCA cases should be tracked but not publicly
reported or used for overall PCI performance
ranking, which would allow accountability for
their management but would not penalize high-
volume cardiac resuscitation centers (CRCs) for
following the 2010 AHA Guidelines for CPR and
ECC. Until an adequate risk adjustment model
is created to account for the numerous out-of-
hospital and in-hospital variables that impact
survival more than the performance of PCI, we
believe that categorizing OHCA STEMI-PCI
cases separately from other STEMI-PCI cases
should occur. These patients should not be
included in public reporting” (5).ETHICAL ISSUES
Ethical challenges are unavoidable in the care of
acutely ill patients resuscitated from OHCA. Although
these challenges cannot be eliminated, there are ways
to maximize ethical decision-making regarding angi-
ography/PCI in this context.
First, there is an ethical imperative for rigorous
research to inform decisions, particularly given het-
erogeneous practice patterns and varied standards of
care. Randomized trials for treatment of cardiac arrest
and other critical illnesses are at times controversial,
largely due to ethical challenges regarding informedconsent (96,97). However, regulations exist to facili-
tate these trials under an exception from informed
consent (98,99). These regulations balance the need
for research with important protections for patients
and communities, and trials conducted under these
regulations have resulted in signiﬁcant insights and
improvements in cardiac arrest care (1,24).
Second, decision-making in treatment of OHCA
requires confronting issues of futility. The proposed
algorithm highlights factors that may help to deﬁne
when angiography/PCI is most likely futile. For
example, a combination of comorbidities, advanced
age, and prolonged ischemia (as indicated by severe
lactic acidosis or long resuscitative efforts) may
signify a high enough chance of multiorgan failure or
anoxic brain injury that the incremental beneﬁt of
restoring coronary perfusion is truly minimal. How-
ever, these predictors are imperfect, and it is un-
known how many unfavorable resuscitation features
result in futility. Moreover, there are no established
thresholds for what chance of a favorable outcome
warrants aggressive treatment. If an intervention
improves expected survival with good neurological
status from 10% to 20%, many physicians or patients
would likely not consider it futile, although the
prognosis remains dismal. In contrast, an improve-
ment from 1% to 2% represents the same relative
beneﬁt, but is likely futile.
Determinations of futility problematically involve
quantitative and qualitative assessments with marked
heterogeneity among providers. Most importantly,
they require judging the value of different outcomes
(100–103). In cardiac arrest, these judgments must be
made without discussing the issues directly with the
patient. Three key ethical implications must be
emphasized in the context of futility in OHCA: 1) ﬁrst,
the unavoidable need for clinical judgment; 2) the need
for better data and prognostic tools; and 3) the need for
transparent discussion at the practice and policy levels
about what characterizes appropriate or futile care.
These discussions should substantially inform policies
regarding reporting practices and quality metrics.
Finally, post-arrest care must involve assessing the
patient’s likely preferences. A key component of
pausing to individualize care is an attempt to contact
family or other proxy decision-makers to assess
whether aggressive treatment is consistent with
the patient’s values or preferences. If pre-existing
advance directives or do not resuscitate orders are
revealed, they should be respected. Perhaps most
importantly, direct and honest communication with
proxy decision-makers is essential to preserving
transparency and trust, and maximizing compati-
bility of decisions with patients’ values and goals.
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71CONCLUSIONS
1. We propose an easily implementable algorithm to
identify resuscitated comatose patients after car-
diac arrest who are appropriate candidates for
emergent coronary angiography.
2. Urgent consultation and evaluation by a multi-
disciplinary team, including the interventional
cardiologist, should occur before the patient is
transferred to the CCL.
3. Early initiation of TTM is strongly recommended.
4. We emphasize our viewpoint and explicitly re-
commend without reservation that PCI outcomesin cardiac arrest patients not be included in public
reporting. A national platform for tracking out-
comes of cardiac arrest patients undergoing PCI is
needed and should distinguish patients with and
without ST-segment elevation.
5. Randomized controlled trials of early PCI in post–
cardiac arrest patients without ST-segment eleva-
tion are needed.
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